4DX:ASX
4DMedical Ltd
A$3.69
arrow_upward
+0.54%(+0.020) 1D
Oct 26, 3:20:22 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4DX...
Open
A$3.65
High
A$3.71
Low
A$3.62
Mkt. cap
2.22B
Avg. vol.
3.66M
Volume
790.34K
52-wk high
A$7.55
52-wk low
A$1.40
EPS
-A$0.38
Shares outstanding
602.24M
No. of employees
181
Open
A$3.65
High
A$3.71
Low
A$3.62
Mkt. cap
2.22B
Avg. vol.
3.66M
Volume
790.34K
52-wk high
A$7.55
52-wk low
A$1.40
EPS
-A$0.38
Shares outstanding
602.24M
No. of employees
181
News stories
From web sources and news partners
bloomingbit
·
37 minutes ago
Hong Kong Names Nasdaq-Listed Solana Company Strategic Enterprise to Support Blockchain Infrastructure
TradingView
·
1 hour ago
Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus
Cryptonews.net
·
14 minutes ago
Hong Kong names Nasdaq-listed Solana Company a strategic enterprise
Bloomberg.com
·
14 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Profile
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd